Investor Relations

Latest Financial Results

Q3 2022

Quarter Ended Sep 30, 2022

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

Company Overview

H-CYTE is a medical biosciences company focused in the field of regenerative medicine. H-CYTE’s mission is to become a leader in next-generation, cellular therapeutics for the treatment of chronic health conditions. 

Investor Contact Information


201 E. Kennedy Blvd
Suite 425
Tampa, FL 02142

Transfer Agent

Interwest Transfer Co., Inc.
1981 Murray Holiday Rd
Ste 100
Salt Lake City, UT 84117
T: (801) 272-9294

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.